Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
A federal judge on Tuesday rejected the Trump administration’s bid to block New York’s so-called Green...
A federal judge on Wednesday said she would block Donald Trump’s administration from laying off hundreds...
A top official at the U.S. Department of Education has been keeping a controversial flag linked...
